Stay updated with breaking news from Mjamesf Howard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression in generalized myasthenia...
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including mini...
Zilbrysq (zilucoplan) is the first self-administered treatment for myasthenia gravis. Rapid symptom improvements were observed in clinical trials.
With the approval, zilucoplan becomes the first once-daily subcutaneous complement C5 inhibitor available for adults with generalized myasthenia gravis.
FDA approval of ZILBRYSQ® (zilucoplan) has been granted for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-ac...